Rankings
▼
Calendar
HRTX
Heron Therapeutics, Inc.
$153M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$2M
67.3% margin
Operating Income
-$49M
-1357.4% margin
Net Income
-$50M
-1385.7% margin
EPS (Diluted)
$-1.00
QoQ Revenue Growth
+184.0%
Cash Flow
Operating Cash Flow
-$51M
Free Cash Flow
-$52M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$190M
Total Liabilities
$87M
Stockholders' Equity
$102M
Cash & Equivalents
$84M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$0
—
Gross Profit
$2M
-$16M
+115.2%
Operating Income
-$49M
-$33M
-48.0%
Net Income
-$50M
-$33M
-50.5%
← FY 2017
All Quarters
Q2 2017 →
HRTX Q1 2017 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena